The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
awarded for 2017 (page 52)..
https://www.valirx.com/wp-content/uploads/2018/04/ValiRx-Annual-Report-2017-Online-PDF.pdf
further to the Company's announcement 17 January 2019, in relation to entering into the Joint Venture Agreement and a definitive Engineering, Procurement and Construction Contract with Power Construction Corporation of China, Ltd ("PowerChina"), it can confirm that it continues to work with PowerChina on formal proposal to the Government of Bangladesh. However, further to the Company's announcement of 27 November 2018, whilst good progress is being made in this regard, the formal proposal will not be made by the initial target date of 28 February 2019. A further announcement(s) will be made in due course, as and when appropriate.
Update sooner now than later 2 months on - good luck all
While the markets which ValiRx is targeting are large, they are all rapidly evolving and contain a number of well-funded “big-pharma” competitors with products that have been approved for market. It is possible that even if ValiRx’s products are eventually approved for sale they may not capture a significantly large enough share of the market to be economic and that developments by competitors may make the products obsolete. ValiRx plans to mitigate the commercial risk by finding a partner or agreeing an out-licensing deal early in the development process.
try 5000 volume on GCM stock sometimes better chance at that volume or
apply fill/kill order - may execute or
apply limit order at band above - may execute or
await movement and requote
There is low stock is issue so expect no quotes often upon price volatility.
http://www.chinadaily.com.cn/m/powerchina/2019-04/26/content_37462917.htm
NWF stock..
he transition of the Stellar shareholder register from Stellar's share registry to Newfield's share registry, Advanced Registry Services, was more problematic than anticipated. Newfield and its registrar received many emails and queries from former Stellar shareholders following completion of the Offer relaying their concerns about a lack of information from brokers and advisors. Transfers of custodial holdings into separate beneficial holder accounts are still being actioned in some instances. Whilst Newfield's intention remains to establish the Facility, the Company has decided to delay the establishment of the Facility until it is confident that the transitional issues with the former Stellar shareholders have been satisfactorily resolved. The Company is hopeful this will occur by the middle of 2019. Former Stellar shareholders with ongoing issues should email Newfield on info@newfieldresources.com.au or contact Advanced Registry Services via their web site at https://www.advancedshare.com.au/contact-us